The Miami Herald, July 29, 2011. NRC President Diana Zuckerman expresses concern over the vast majority of medical devices being cleared through the 510(k) process—a process which has been described as “flawed” by Institute of Medicine panelists in a new report.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Backs Quicker Reviews for Hip Implants in Reply to Panel’s Report
Bloomberg, July 29, 2011. In an article about the IOM medical device report and the FDA, president of the National Research Center for Women & Families Diana Zuckerman tells Bloomberg: devices that are implanted and “life-sustaining and life- saving should be held to a higher standard.”
Read More »Experts Say FDA Should Abandon Approval Process
ABC, July 29, 2011. NRC President Diana Zuckerman tells ABC that found that in 2010 more than 437 million devices were recalled out of fear that they might kill or permanently harm patients.
Read More »Warning About Pelvic Mesh
WCAX, July 15, 2011. NRC President Diana Zuckerman tells WCAX that pelvic mesh devices have “been used despite no clinical trials, no testing on humans to see if they’re actually safe and effective.
Read More »Report Could Sway FDA Device Review Process
Reuters, July 26, 2011. President of the National Research Center for Women & Families Diana Zuckerman is critical of the FDA for not moving sooner to make changes to the device approval process. She says “the whole process is illogical” and “in some kind of ideal world the FDA would have come out with these proposals and implemented them.”
Read More »


